| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |